Contrast medium- (CM) induced nephropathy may be evident from symptoms
ranging from acute renal failure to minor changes in tubular function
tests. While the incidence is usually low, it increases with the pres
ence of risk factors and when arterial injections are made. The pathog
enesis is not fully understood. No specific therapy exists, but in mos
t cases it can be prevented by ensuring that the patient is well hydra
ted prior to injection of CM. The extended phase I study with iodixano
l (Visipaque) included detailed investigations on its renal effects. N
o changes in glomerular filtration rate (GFR) were found. Even though
enzymuria was less pronounced after injection of iodixanol than after
various monomeric CM, a somewhat higher degree of intrarenal retention
of CM was observed on CT examination of the kidneys after iodixanol.
In nondiabetic patients suffering from severe renal failure, angiograp
hy with either iodixanol or iohexol caused no changes in GFR, or in ur
inary excretion of protein and enzymes. However, a higher degree of co
ntrast retention than that seen in healthy volunteers was found.